Announced
Biogen to acquire the remaining 89.8% stake in Sage Therapeutics in a $442m deal.
Synopsis
Biogen, a biotechnology company, offered to acquire the remaining 89.8% stake in Sage Therapeutics, a biopharmaceutical company, in a $442m deal.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2025 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.